Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (37)
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
1990 • 1,882 citations
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
1990 • 1,300 citations
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
1994 • 575 citations
Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1
2000 • 420 citations
Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia
1997 • 375 citations
Expression of the Wilms' tumor gene (WT1) in human leukemias.
1992 • 354 citations
HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide
2000 • 351 citations
Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis
1996 • 268 citations
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
1995 • 263 citations
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia
2002 • 259 citations
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene ( WT1 ) product
2000 • 250 citations
Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level
2000 • 242 citations
Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.
1999 • 223 citations
Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
1999 • 216 citations
Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product
2000 • 211 citations
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers
2002 • 205 citations
High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
2002 • 202 citations
The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes
1999 • 188 citations
Wilms' Tumor Gene (WT1) Competes With Differentiation-Inducing Signal in Hematopoietic Progenitor Cells
1998 • 178 citations
Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.
1993 • 152 citations
Immunity to WT1 in the animal model and in patients with acute myeloid leukemia
2000 • 144 citations
Wilms’ Tumor GeneWT1: Its Oncogenic Function and Clinical Application
2001 • 130 citations
Humoral immune responses against Wilms tumor gene WT1product in patients with hematopoietic malignancies
2002 • 124 citations
The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?
1998 • 121 citations
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.
1994 • 115 citations
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues
2002 • 115 citations
Constitutive expression of the Wilms’ tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
1999 • 99 citations
WT1 as a Novel Target Antigen for Cancer Immunotherapy
2002 • 75 citations
Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination.
2000 • 75 citations
Antilung cancer effect of WT1-specific cytotoxic T lymphocytes.
2002 • 57 citations
HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria
2002 • 53 citations
Myelodysplastic syndrome: review of the cytogenetic and molecular data
2001 • 51 citations
Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
1995 • 49 citations
Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome
2000 • 46 citations
Cancer Immunotherapy Targeting WT1 Protein
2002 • 40 citations
Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence‐activated cell sorting
2000 • 38 citations
Development of HLA‐A2402/Kb transgenic mice
2002 • 28 citations